ARTICLE

Trustworthy AI in Drug Discovery

This article examines how AI-driven drug discovery is moving from experimental innovation toward trustworthy, regulatory-ready implementation. It discusses validation, interpretability...

INTERVIEW

AI Powering the Next Era of Pharma

Artificial Intelligence is reshaping pharmaceutical innovation by accelerating drug discovery, enabling predictive formulation development, advancing precision medicine...

NEWS

Armata Pharma Secures FDA Deal on AP-SA02 Paediatric Study Plan

Armata Pharmaceuticals has received agreement from the US Food and Drug Administration FDA on its Initial Paediatric Study Plan iPSP for APSA supporting the future evaluation...

PROJECTS

Boehringer Ingelheim Invests US$204 million to Expand UK AI Hub

Boehringer Ingelheim is expanding its global Computational Innovation network with a new artificial intelligence (AI) and machine learning (ML) centre in King’s Cross, London...

PRESS RELEASE

AstraZeneca Secures Zegfrovy License from Dizal

AstraZeneca has entered into an exclusive license agreement with Dizal Pharmaceutical Co., Ltd for Zegfrovy (sunvozertinib), a novel oral irreversible epidermal growth...

LATEST APPOINTMENTS

TECHNO TRENDS

Merck's Calderasib Earns FDA Breakthrough Status for Lung Cancer

VERTANICAL has achieved an important regulatory milestone after the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to VER-01, an...

RESEARCH INSIGHTS

Hypoxia-Related Genes Predict Lung Adenocarcinoma Outcomes

Lung Adenocarcinoma and Hypoxia Lung cancer remains one of the most common and deadly cancers worldwide, with non-small cell lung cancer (NSCLC) being the dominant...